US President Donald Trump recently caused a stir by linking the painkiller acetaminophen (known as Tylenol in the US) to the increase in autism diagnoses in children. This claim, made during a White House press conference, not only shocked experts but also sparked a debate about the scientific evidence behind such claims. Despite the global increase in autism cases, the alleged link to acetaminophen remains unproven. Trump also expressed doubts about the hepatitis B vaccination for infants, which experts are skeptical about. However, the US Food and Drug Administration (FDA) does not plan to change its recommendations regarding the use of acetaminophen. This report critically examines the acetaminophen conspiracy theory and compares it with current research findings.
The controversial claim: Trump’s connection between paracetamol and autism
Paracetamol, which is sold in Germany under names such as Paracetamol-ratiopharm, Dolormin, or Grippostad, is one of the most widely used medications for pain and fever worldwide. Despite its widespread use, Trump warned pregnant women against taking paracetamol without hesitation and announced that the FDA would soon inform doctors about an increased risk of autism.
Scientific studies, however, contradict this claim. Sven Bölte, head of the Center for Developmental Disorders at the Karolinska Institute, explains that autism is related to neurological development and the functioning of the central nervous system. Any possible connection between paracetamol and autism is extremely small and has only a minimal effect. The main reason for the increasing number of autism diagnoses is, he says, improved diagnostic procedures and a better understanding of the disorder.
| Factors | Explanation |
|---|---|
| Paracetamol | Worldwidely used painkiller, no reliable evidence for autism risk |
| Autism diagnoses | Increasing case numbers due to improved diagnostics and awareness |
| Genetics and environment | Complex interplay of various factors influences autism |
| Vaccinations | No scientific evidence of a connection to autism |
Vaccination criticism and its consequences
In addition to his statements about paracetamol, Trump questions the necessity of the hepatitis B vaccination in infancy. Hepatitis B is primarily sexually transmitted, which is why Trump recommends starting vaccination only at age 12. However, scientific studies show that infants in particular have a higher risk of chronic hepatitis B disease, which medically justifies early vaccination.
The Robert Koch Institute confirms that the hepatitis B vaccination in infancy is useful in drastically reducing the likelihood of chronic disease. While approximately 10 percent of hepatitis B infections in adults become chronic, the risk is as high as 90 percent in infants.
Impact of the statements on the American healthcare system
Trump’s expressed skepticism about acetaminophen and vaccinations is causing considerable concern among experts. Although the FDA continues to endorse the safety of acetaminophen and has not recommended restricting its use, the uncertainty caused by the president’s statements could reduce drug acceptance.
Market leaders in the field of paracetamol and other painkillers, such as Bayer, Hexal, Ratiopharm, Stada, Berlin-Chemie, and Sanofi Germany, offer a wide variety of products such as Aspirin, Grippostad, Dolormin, and Paracetamol-ratiopharm, which are used by millions of people daily. Continued skepticism could not only harm consumer health but also have economic repercussions for pharmaceutical manufacturers.
| Pharmaceutical companies | Product examples | Market position |
|---|---|---|
| Bayer | Aspirin, Grippostad | Major manufacturer in Europe |
| Hexal | Paracetamol, painkillers | Major generic manufacturer |
| Ratiopharm | Paracetamol-ratiopharm | Major generic supplier |
| Stada | Pain medications | Vienna market leader |
| Berlin-Chemie | Pain medications, various therapies | Broad portfolio |
| Sanofi Germany | Paracetamol and others | Global pharmaceutical group |
Source: taz.de
